Medco Health Solutions, Inc. & Affiliates (formerly Medco Health Solutions, Inc.)
Registered Principal Details
Cessation Date
6/8/2012 12:00:00 AM
Business Or Interest:
Pharmacy Benefits Management
Lobbying Interests:
All matters relating to pharmaceuticals, pharmacy benefits management and prescription drug programs.
CEO Name:
David B. Snow, Jr
VP, Government Affairs
6/8/2012 12:00:00 AM
Business Or Interest:
Pharmacy Benefits Management
Lobbying Interests:
All matters relating to pharmaceuticals, pharmacy benefits management and prescription drug programs.
CEO Name:
David B. Snow, Jr
VP, Government Affairs
Contact
PH
Peter Harty
19520 Yellow Wing Ct
Colorado Springs, CO 80908
(719) 487-3009
(719) 352-0260
peter_harty@medco.com
19520 Yellow Wing Ct
Colorado Springs, CO 80908
(719) 487-3009
(719) 352-0260
peter_harty@medco.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Jason E Johns | Exclusive Duties N/A | Authorized On 1/20/2011 | Withdrawn On 8/24/2011 |
| Jeffrey Schoenfeldt | Exclusive Duties N/A | Authorized On 10/24/2011 | Withdrawn On 6/8/2012 |
| Forbes McIntosh | Exclusive Duties N/A | Authorized On 10/24/2011 | Withdrawn On 6/8/2012 |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 440
Relating to: electronic prescriptions for schedule II controlled substances.
Bill Text and History
1/27/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: electronic prescriptions for schedule II controlled substances.
Bill Text and History
Other
Notification Date1/27/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 360
Relating to: the minimum sale price of prescription drugs.
Bill Text and History
1/11/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: the minimum sale price of prescription drugs.
Bill Text and History
Other
Notification Date1/11/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Legislation or proposals on pedigree drug prescription programs.
Legislation or proposals on pedigree drug prescription programs.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
pharmacy benefits managers
pharmacy benefits managers
Action Intended To Affect
Rule (by a state agency)
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Rule (by a state agency)
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Requiring physicians to prescribe brand name drugs thus prohibiting prescribing an equivalent generic substitute.
Development, drafting or introduction of a proposal relating to
Requiring physicians to prescribe brand name drugs thus prohibiting prescribing an equivalent generic substitute.
Requiring physicians to prescribe brand name drugs thus prohibiting prescribing an equivalent generic substitute.
Action Intended To Affect
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2011 January - June |
2011 July - December |
2012 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2011 January - June $21,000.00 |
2011 July - December $21,000.00 |
2012 January - June $17,922.20 |
Total $59,922.20 |
| Total Hours Communicating | 2011 January - June 0.00 |
2011 July - December 3.50 |
2012 January - June 27.00 |
Total 30.50 |
| Total Hours Other | 2011 January - June 41.00 |
2011 July - December 35.25 |
2012 January - June 69.50 |
Total 145.75 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: electronic prescriptions for schedule II controlled substances.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June 20% |
2012 July - December |
Total 11% |
Relating to: the minimum sale price of prescription drugs.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December |
2012 January - June 40% |
2012 July - December |
Total 22% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December 25% |
2012 January - June 10% |
2012 July - December |
Total 11% |
Requiring physicians to prescribe brand name drugs thus prohibiting prescribing an equivalent generic substitute.
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December 25% |
2012 January - June 10% |
2012 July - December |
Total 11% |
| 2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
|---|---|---|---|---|
| 2011 January - June |
2011 July - December 50% |
2012 January - June 20% |
2012 July - December |
Total 22% |
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication